Experience

A fine
balance

The passion you want at your side, plus the experience you want at the table.

Meet Our Team

More

Team

Greater perspectives create greater outcomes.

Balance, diversity and passion are at the core of who we are. Meet the hardworking people who defy convention, shatter glass ceilings, and take companies to the top—all with a unique style and a healthy dose of humor.

Companies

A dynamic
portfolio

Across healthcare and technology, we partner with companies that improve lives.

See Our Companies

More

Companeis

The future looks bright.

Say hello to our extended family. An impressive roster of agile and imaginative companies that are building the future of healthcare and technology, one big idea at a time. Our portfolio of entrepreneurial muscle includes 59 IPOs and 134 M&As. And counting.

Approach

A hand
in every stage

From the first handshake to the final round, we do what it takes to bring your vision to life.

Learn About Our Approach

More

About

This is Canaan.

Canaan is an early-stage venture capital firm that invests in visionaries with transformative ideas. While we love speedy success, we’re acutely aware that greatness comes in many forms and at different times. That’s why we’re not afraid to break the mold to bring something spectacular to life.

The passion you want at your side, plus the experience you want at the table.

Meet Our Team

Across healthcare and technology, we partner with companies that improve lives.

See Our Companies

From the first handshake to the final round, we do what it takes to bring your vision to life.

Learn About Our Approach

Highlights

STAT News: Antiva tried to drum up interest for a much-needed drug. Many men didn’t get it

STAT News: Antiva tried to drum up interest for a much-needed drug. Many men didn’t get it

Antiva is working on a first-in-class treatment that, if successful, could make surgery for precancerous cervical lesions caused by the human papillomavirus unnecessary. But when it comes to making that case to investors and doctors — particularly the men who dominate those professions — it has often been an uphill battle.

Bloomberg: World View wants to send you to the stratosphere in a balloon

Bloomberg: World View wants to send you to the stratosphere in a balloon

World View has figured out how to keep a capsule stable 100,000 feet above the Earth. Interested in a ride?

Announcing ScaleFactor: Automated financial operations platform built for Main Street

Announcing ScaleFactor: Automated financial operations platform built for Main Street

We're investing in ScaleFactor, a company focused on empowering small businesses to easily make the best strategic and financial decisions so they can keep their focus on their customers.

Canaan Beta for Alpha

Canaan Beta for Alpha

We’re excited to be launching Canaan Beta, Canaan’s new $20 million seed program that aims to invest in the next wave of consumer technologies across social, eCommerce, gaming and even sectors that haven’t yet been imagined.

"Jumping together" to move the field of personalized cancer therapy

"Jumping together" to move the field of personalized cancer therapy

We at Canaan are “all in” on the notion that diversity of knowledge and experience breeds the best results. With this as our core value, PACT Pharma immediately captured our imagination and investment.

Ownership: a big idea to transform the current brand-loyalty model

How far have loyalty programs come in actually cultivating true loyalty from consumers, as opposed to just transactions? Introducing our newest investment in Bumped, which offers the most valuable loyalty tool of all – ownership.

Enjoying an AI summer

Enjoying an AI summer

It's been decades in the making, but the current AI summer is going to be a long one. Read more from AI industry veteran and investor, Rich Boyle on the history to get here and what’s next.

More hope for cystic fibrosis treatment, and still more to do

More hope for cystic fibrosis treatment, and still more to do

The progress made in the treatment of CF is shows what can happen when research, policy, advocacy and investment align toward a common goal. But more has to be done.

The Next Generation of Computation

The Next Generation of Computation

Professor Robert Schoelkopf of QCI inside a lab at Yale University. Photo Credit: Roger Kisby for The New York Times

The New Yorker: The RealReal’s radical vision of secondhand luxury

The New Yorker: The RealReal’s radical vision of secondhand luxury

An inside look at how The RealReal is redefining consignment for its 8 million members (and counting).

Spotlight on Wende Hutton’s 25 years in venture capital

Spotlight on Wende Hutton’s 25 years in venture capital

General Partner Wende Hutton is an industry pioneer. Partner Julie Grant chatted with Wende about today’s scientific renaissance, the importance of a team approach and the difference between active and activist investor.

Video: Introducing The Makers, featuring Dan Ciporin & Amir Ashkenazi

Video: Introducing The Makers, featuring Dan Ciporin & Amir Ashkenazi

The Makers is a new Canaan content series featuring entrepreneur and investor insights into company-building.

A Critical Marriage for Science and Health Tech

A Critical Marriage for Science and Health Tech

The prehistoric nature of health IT isn’t just a nuisance. It will literally determine whether patients and physicians can realize the potential of cell and gene therapies.

What Home Is

What Home Is

Meet our newest investment Homeis. A new kind of social network that connects foreign born locals with one another, and their roots.

What's Rarer than a Unicorn in Silicon Valley? A Female VC.

What's Rarer than a Unicorn in Silicon Valley? A Female VC.

Canaan Associate Laura Chau reflects on the 3 major takeaways she's learned from women in venture capital

IDEAYA & the Next Frontier in Synthetic Lethality

IDEAYA & the Next Frontier in Synthetic Lethality

WSJ: Ideaya Biosciences Collects $94 Million for Cancer Therapy

The Roadmap for Board Diversity

The Roadmap for Board Diversity

Diversity is not window dressing. It is a positive predictor of performance and governance.

Built to Last

Built to Last

Excited to share news about our new $800 million fund. We know what works and we're sticking to it with our diversified, early stage approach.

World View

World View

New York Times: A chicken sandwich hitches a balloon ride to the stratosphere.

Spotlight: Q&A with Rich Boyle

Spotlight: Q&A with Rich Boyle

Get to know our newest GP and longtime startup operator Rich Boyle. Word to the wise: don't throw the term AI around with him unless you mean it.

Annum

Annum

Heavy drinking is the largest ignored epidemic in the U.S. There is a superior alternative to rehab.

Body Politic Series: Women's access to healthcare

Body Politic Series: Women's access to healthcare

The first installment of this series couldn't have been more timely.

Protagonist Therapeutics

Protagonist Therapeutics

A simple promise: replacing injections with pills.

Activity